Amphiphilic polysaccharide derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6245753
SERIAL NO

09300173

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Polysaccharides, which are widely used as an anticoagulation drugs, especially heparin, are clinically administered only by intravenous or subcutaneous injection because of their strong hydrophilicity and high negative charge. Amphiphilic heparin derivatives were synthesized by conjugate to bile acids, sterols, and alkanoic acids, respectively. The hydrophobicity of the heparin derivatives depended on the feed mole ratio of heparin to hydrophobic agent. The heparin derivatives were slightly hydrophobic and exhibited good solubility in a water-acetone solvent, as well as water. The heparin derivatives have a high anticoagulant activity. These slightly hydrophobic heparin derivatives can be absorbed in gastric intestinal tract and can be used as oral dosage form. Also, the heparin derivatives can be used for the surface modification to prevent anticoagulation for medical devices such as extracorporeal devices and implanted devices.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIPLEX CORPORATION KOREA2703 TRADE TOWER 159-1 SAMSUNG-DONG KANGNAMKU SEOUL 135-729

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Byun, Youngro Kwangju, KR 21 439
Lee, Yong-Kyu Kwangju, KR 80 1441

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation